Lithium chloride was given intraperitoneally to dogs at a dosage of 125 mg/kg body weight for three days. Kidneys were removed for morphologic examination and quantitation of sodium-potassium-adenosine triphosphatase (Na-K-ATPase) activity in cortical and medullary tissue. Light microscopy showed no changes in the kidneys, but cytoplasmic vacuolation and dilatation of the cisternae of the endoplasmic reticulum were seen ultrastructurally in the epithelial cells of the distal tubule and cortical and medullary collecting ducts. Mean cortical Na-K-ATPase activity was 1.49 f 0.25 and 1.70 k 0.31 pmoles inorganic phosphate/mg protein/hour in control and experimental groups respectively. Mean medullary Na-K-ATPase activity was 4.71 f 0.41 and 5.01 f 0.47 pmoles inorganic phosphate/mg protein/hour in control and experimental groups respectively. It was concluded that lithium produced morphologic changes in the distal nephron, but had no effect on renal Na-K-ATPase activity.
Lithium is widely used for the management of affective disorders in man, and its use in other conditions pertinent to veterinary medicine is being studied [6, 421. Lithium is not an innocuous substance, and people on long-term maintenance may develop some potentially harmful side effects. Of particular interest are lithiuminduced polyuria [4] and renal tubular acidosis [37] . The pathogenesis of these disorders has not been defined. It has been suggested that polyuria is caused by inhibition of vasopressin-dependent adenyl cyclase in the renal collecting ducts [43] , but others have claimed that lithium acts distal to cyclic adenosine monophosphate generation in these cells [7, 301. It has also been suggested that lithium causes a loss of medullary concentrating ability by decreasing sodium resorption in the thick ascending loop of Henle [ 1 I]. Depletion of potassium may contribute to the polyuria [4] , and potassium supplementation has been shown to ameliorate lithium-induced polyuria and natriuresis [35] . The renal tubular acidosis has been shown to be caused at least partially by lithium being present in the tubular epithelial cell, rather than solely within the lumen as an unabsorbable cation [31] . It has been suggested that lithium causes decreased distal tubular hydrogen ion secretion or increased backdiffusion of acid from the lumen to the epithelium [33] . Recently it has been proposed that the decreased acid secretion is the result of increased intraluminal electropositivity caused by decreased sodium resorption [5] .
The mechanism of action of lithium itself is still a subject of active investigation. Much of the information from studies of the action and use of lithium has been compiled into two books [21, 221. Many mechanisms have been proposed for the action of lithium; probably a combination of reactions occurs in vivo to produce a net effect. These reactions include interference with adenyl cyclase and cyclic adenosine monophosphate [7, 30, 461, modulation of prostaglandin synthesis [ 19, 32, 391 , competition with other ions in carrier molecules [9] , inhibition of enzymes [27, 401, decreased energy production [2], and production of intracellular alkalosis [3] .
Much attention has been focused on the effect of lithium on sodium-potassiumadenosine triphosphatase (Na-K-ATPase), and it is apparent that there are species, organ, and individual differences [12, 14, 15, 17, 361. Since lithium can activate Na-K-ATPase in erythrocytes and inhibit it in some nervous tissue [14, 361, it is possible that its action in the kidney is mediated at least partially through this enzyme also. Sodium maleate has been shown to produce a renal tubular dysfunction by inhibiting renal Na-K-ATPase [25] . Inhibition of renal Na-K-ATPase by lithium would support the hypothesis that decreased sodium resorption is responsible for the side effects of polyuria and renal tubular acidosis [5, 111. The effect of lithium on the morphology of the kidney is unclear. Lesions reported in people receiving lithium have included minimal change disease and the nephrotic syndrome This study investigates further the effects of lithium on renal morphology and Na-K-ATPase activity.
Materials and Methods
Fourteen mongrel dogs weighing six to 30 kg were divided into control and experimental groups of seven each. Lithium chloride was given intraperitoneally to the principals (experimental group) at a dose of 125 mg/kg/day for three days [33] , and the dogs were killed 24 hours after the last injection. The kidneys were removed immediately and processed for light and electron microscopy and measurement of enzyme activity. The identity of the specimens was unknown at the time of examination.
Small pieces of cortex and medulla were fixed for two hours at 4°C in 3% glutaraldehyde in 0.1 M Sorensen's phosphate buffer, pH 7.3. Samples were post-fixed in 1% osmium tetroxide in the same buffer for one hour at 4°C. The samples were dehydrated through increasing grades of alcohol and embedded in epon. Ultrathin sections were cut on a LKB Ultratome IV (LKB, Bromma, Sweden), stained with 2% aqueous uranyl acetate and lead citrate, and examined in an electron microscope. Examination of the glomeruli, proximal and distal tubules, cortical and medullary collecting ducts, thin and thick loops of Henle, and vasa recta was made in all dogs.
Sections of kidney were fixed in 10% neutral buffered formalin, embedded in paraffin, cut at 4 pm, and stained with hematoxylin and eosin (HE) and periodic acid-Schiff (PAS).
Homogenates of renal medulla and cortex were prepared in a 5: 1 (v:w) solution containing 0.25 M sucrose, 5 mM sodium ethylenediaminetetracetate, 38 mM Tris buffer (Sigma Chemical Company, St. Louis, Mo.), and 2.4 mM deoxycholate at pH 6.8 for three minutes in a Stomacher Lab Blender, Model 80 (Dynatech Laboratories, Inc., Alexandria, Va.). Tissues and homogenates were kept chilled in ice-baths throughout the procedures. Concentrations of Na-K-ATPase in each homogenate were determined in duplicate [23] . ATPase activity was expressed in pmoles of inorganic phosphate released per mg of protein per hour. Phosphate was determined by a modification of a published method [45] (Data Medical Associates, Inc., Arlington, Tex.), and protein was determined by the Coomassie Brilliant Blue dye binding procedure (Bio-rad Laboratories, Richmond, Calif.) [8]. Control and experimental data were compared with Student's t test for unpaired samples.
Results
The kidneys of all dogs looked normal by light microscopy, and there were no differences between the two groups. The only striking ultrastructural change found in all experimental dogs was the presence of many large clear spaces in the cytoplasm of the epithelium of the distal tubules and collecting ducts ( fig. 1, 2) . These spaces were produced by dilatation of the rough endoplasmic reticulum and by vacuolation. Similar vacuoles were seen in the control dogs but they were never as extensive or as large as those in the experimental dogs. An occasional lithium-treated dog had wide intercellular spaces in the basal infoldings of the distal tubular epithelium.
The glomeruli, proximal tubules, loops of Henle, and vasa recta looked normal in all dogs. The two groups had similar numbers of cytobodies and apical vesicles in the tubular epithelium. Mitochondria in both groups occasionally were swollen and mottled. No evidence of necrosis was found.
There were no significant differences in cortical and medullary Na-K-ATPase activity between control and lithium-treated dogs ( fig. 3 ). Mean cortical Na-K-ATPase activity in controls was 1.49 f 0.25 pmoles inorganic phosphate/mg protein/ hour, whereas lithium-treated dogs had mean cortical activity of 1.70 f 0.3 1 pmoles inorganic phosphate/mg protein/hour. Mean medullary activity was 4.7 1 f 0.41 and 5.0 1 f 0.47 pmoles inorganic phosphate/mg protein/hour in controls and principals respectively.
Discussion
The normal Na-K-ATPase activity found in these dogs following treatment with lithium differs from the increase reported in the renal medulla of rats [15, 381. This could be a species difference or it could be the result of the acuteness of this study, since the increase in rats followed long-term lithium administration. It is also likely that the increased enzyme activity following long-term lithium treatment in rats resulted from increased aldosterone secretion in response to lithium-induced natriuresis [ 151.
This experiment indicates that lithium has no direct effect on renal Na-K-ATPase in dogs. If the side effects of lithium treatment are caused by decreased sodium resorption in the tubules as suggested [5, 111, this process would have to be mediated by means other than Na-K-ATPase inhibition. It has been shown that lithiuminduced natriuresis is mediated by both an aldosterone-dependent and an aldosterone-independent mechanism [47, 481. The effect of lithium on aldosterone is to inhibit the response of the distal nephron to the hormone so that distal sodium resorption is diminished. The concomitant increase in aldosterone secretion [ 151 is probably a compensatory mechanism for the inhibition by lithium.
The aldosterone-independent mechanism has not been identified. Others have suggested that lithium acts by decreasing proximal resorption of sodium [5, 111. Perhaps this proximal inhibition is caused simply by competition of lithium for the luminal carrier site for sodium or the basolateral ouabain-insensitive carrier site for sodium (or both). It is apparent that lithium does not compete significantly for the intracellular sodium site of the ouabain-sensitive carrier (Na-K-ATPase) but does so very effectively for the ouabain-insensitive, phloretin-sensitive carrier of erythrocytes [36] . It is known that the epithelial cells of the proximal tubule have a phloretinsensitive carrier for glucose at their basolateral membranes and that one of the sodium carriers in the luminal membrane is a sodium-glucose-cotransport carrier [50] . It is possible therefore that the phloretin-sensitive glucose carrier in the basolateral membranes is also a sodium-cotransport carrier, and it may be the same sodium-lithium phloretin-sensitive carrier described in erythrocytes [36] . Since this carrier in erythrocytes has been shown to have a 15-to 18-fold greater affinity for lithium than for sodium, the presence of intracellular lithium in the epithelium of the proximal tubule would significantly decrease the amount of sodium moving through the cells from the lumen into the peritubular fluid. If the mechanism of lithiuminduced natriuresis is simply competition for carrier sites for sodium, that would account for the protective effect of sodium chloride in lithium intoxication. Such a mechanism is also compatible with renal lithium excretion studies [44, 491. The vacuolation in the distal nephron seen in this study and reported by others [ 10, 13, 24, 341 may be pathologic and associated with the natriuresis, polyuria, and distal renal tubular acidosis caused by lithium. These conditions were not studied in this experiment, so such an association is speculative. The location of the vacuolation, however, corresponds to the segment of the nephron where lithium has been shown to cause functional abnormalities (inhibition of aldosterone and distal renal tubular acidosis). It is possible also that the vacuoles represent an attempt by the distal nephron to recapture water lost proximally if the natriuretic effect of lithium is mediated in the proximal nephron. The dilated intercellular spaces seen in the distal tubules in these dogs suggest this possibility.
None of the morphologic changes seen in people receiving lithium were seen in our dogs; these reported changes, however, have followed longer periods of treatment. Our dogs did not have the glomerular changes and diffuse Golgi hypertrophy in epithelial cells reported in lithium-treated rats, but those changes were seen only after 15 days of treatment [28] . The karyolysis and karyorrhexis reported in the distal nephron of rats [I31 and dogs [34] were not seen in our experiment; these changes occurred only after prolonged lithium treatment.
The diversity of lesions found in the kidneys of people maintained on lithium has been discussed recently [ZO] , and it was concluded that the lack of specificity of lesions and the absence of correlation between morphologic changes and functional impairment make it difficult to relate lithium damage to actual occurrences of chronic renal failure. It is apparent that further investigation into the morphologic and functional effects of lithium therapy is warranted.
